These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


423 related items for PubMed ID: 20482453

  • 1. Beta-lactamases identified in clinical isolates of Pseudomonas aeruginosa.
    Zhao WH, Hu ZQ.
    Crit Rev Microbiol; 2010 Aug; 36(3):245-58. PubMed ID: 20482453
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. OXA-type beta-lactamases among extended-spectrum cephalosporin-resistant Pseudomonas aeruginosa isolates in a university hospital in southern Taiwan.
    Yan JJ, Tsai SH, Chuang CL, Wu JJ.
    J Microbiol Immunol Infect; 2006 Apr; 39(2):130-4. PubMed ID: 16604245
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of phenotypic tests for the detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a low prevalence country.
    Samuelsen O, Buarø L, Giske CG, Simonsen GS, Aasnaes B, Sundsfjord A.
    J Antimicrob Chemother; 2008 Apr; 61(4):827-30. PubMed ID: 18227087
    [Abstract] [Full Text] [Related]

  • 8. Characterization of acquired β-lactamases in Pseudomonas aeruginosa and quantification of their contributions to resistance.
    Glen KA, Lamont IL.
    Microbiol Spectr; 2024 Oct 03; 12(10):e0069424. PubMed ID: 39248479
    [Abstract] [Full Text] [Related]

  • 9. [Resistance caused by hyperproduction of chromosomal beta-lactamase in Pseudomonas aeruginosa].
    Tirado M, Hermida M, Reig R, Esteva C, Vidal R, Roy C.
    Enferm Infecc Microbiol Clin; 1989 Dec 03; 7(10):530-4. PubMed ID: 2518765
    [Abstract] [Full Text] [Related]

  • 10. Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres).
    Dubois V, Arpin C, Dupart V, Scavelli A, Coulange L, André C, Fischer I, Grobost F, Brochet JP, Lagrange I, Dutilh B, Jullin J, Noury P, Larribet G, Quentin C.
    J Antimicrob Chemother; 2008 Aug 03; 62(2):316-23. PubMed ID: 18467306
    [Abstract] [Full Text] [Related]

  • 11. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms.
    Gad GF, El-Domany RA, Zaki S, Ashour HM.
    J Antimicrob Chemother; 2007 Nov 03; 60(5):1010-7. PubMed ID: 17906321
    [Abstract] [Full Text] [Related]

  • 12. Clinically significant carbapenemases: an update.
    Walsh TR.
    Curr Opin Infect Dis; 2008 Aug 03; 21(4):367-71. PubMed ID: 18594288
    [Abstract] [Full Text] [Related]

  • 13. New beta-lactamases: a paradigm for the rapid response of bacterial evolution in the clinical setting.
    Rossolini GM, Docquier JD.
    Future Microbiol; 2006 Oct 03; 1(3):295-308. PubMed ID: 17661642
    [Abstract] [Full Text] [Related]

  • 14. [Carbapenemases in Pseudomonas spp].
    Juan Nicolau C, Oliver A.
    Enferm Infecc Microbiol Clin; 2010 Jan 03; 28 Suppl 1():19-28. PubMed ID: 20172419
    [Abstract] [Full Text] [Related]

  • 15. A Pseudomonas aeruginosa isolate producing the GES-5 extended-spectrum beta-lactamase.
    Wang C, Cai P, Chang D, Mi Z.
    J Antimicrob Chemother; 2006 Jun 03; 57(6):1261-2. PubMed ID: 16617065
    [No Abstract] [Full Text] [Related]

  • 16. Prevalence of AmpC over-expression in bloodstream isolates of Pseudomonas aeruginosa.
    Tam VH, Schilling AN, LaRocco MT, Gentry LO, Lolans K, Quinn JP, Garey KW.
    Clin Microbiol Infect; 2007 Apr 03; 13(4):413-8. PubMed ID: 17359326
    [Abstract] [Full Text] [Related]

  • 17. Characterization of poxB, a chromosomal-encoded Pseudomonas aeruginosa oxacillinase.
    Kong KF, Jayawardena SR, Del Puerto A, Wiehlmann L, Laabs U, Tümmler B, Mathee K.
    Gene; 2005 Sep 26; 358():82-92. PubMed ID: 16120476
    [Abstract] [Full Text] [Related]

  • 18. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.
    Llanes C, Pourcel C, Richardot C, Plésiat P, Fichant G, Cavallo JD, Mérens A, GERPA Study Group.
    J Antimicrob Chemother; 2013 Aug 26; 68(8):1763-71. PubMed ID: 23629014
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of genetic determinants involved in beta-lactam- and multiresistance in a surgical ICU.
    van Loon HJ, Box AT, Verhoef J, Fluit AC.
    Int J Antimicrob Agents; 2004 Aug 26; 24(2):130-4. PubMed ID: 15288311
    [Abstract] [Full Text] [Related]

  • 20. Detection of a new extended-spectrum oxacillinase in Pseudomonas aeruginosa.
    Fournier D, Hocquet D, Dehecq B, Cholley P, Plésiat P.
    J Antimicrob Chemother; 2010 Feb 26; 65(2):364-5. PubMed ID: 20008045
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.